Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
Rambaldi, Alessandro
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study. [electronic resource] - Leukemia 08 2020 - 2234-2237 p. digital
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't
1476-5551
10.1038/s41375-020-0735-y doi
Adult
Aged
Aged, 80 and over
Carbamates--adverse effects
Female
Humans
Janus Kinase 2--genetics
Male
Maximum Tolerated Dose
Middle Aged
Mutation
Polycythemia Vera--drug therapy
Quality of Life
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study. [electronic resource] - Leukemia 08 2020 - 2234-2237 p. digital
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't
1476-5551
10.1038/s41375-020-0735-y doi
Adult
Aged
Aged, 80 and over
Carbamates--adverse effects
Female
Humans
Janus Kinase 2--genetics
Male
Maximum Tolerated Dose
Middle Aged
Mutation
Polycythemia Vera--drug therapy
Quality of Life